Reuters logo
3 months ago
BRIEF-Advaxis and Bristol-Myers Squibb announce clinical collaboration to evaluate ADXS-DUAL and Opdivo in metastatic cervical cancer
May 30, 2017 / 11:15 AM / 3 months ago

BRIEF-Advaxis and Bristol-Myers Squibb announce clinical collaboration to evaluate ADXS-DUAL and Opdivo in metastatic cervical cancer

May 30 (Reuters) - Advaxis Inc

* Advaxis and Bristol-Myers Squibb announce clinical collaboration to evaluate ADXS-DUAL and opdivo (nivolumab) in metastatic cervical cancer

* Bristol-Myers Squibb Co says Advaxis will sponsor study and pay third-party costs

* Bristol-Myers Squibb Co - Under terms of agreement, each party will bear their own internal costs and provide its immunotherapy agents.

* Bristol-Myers squibb -Study expected to start by end of year Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below